BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 68 filers reported holding BIODELIVERY SCIENCES INTL IN in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $42,000 | +13.5% | 15,635 | 0.0% | 0.01% | +11.1% |
| Q2 2016 | $37,000 | -27.5% | 15,635 | 0.0% | 0.01% | -25.0% |
| Q1 2016 | $51,000 | -32.0% | 15,635 | 0.0% | 0.01% | -33.3% |
| Q4 2015 | $75,000 | +11.9% | 15,635 | +29.3% | 0.02% | 0.0% |
| Q3 2015 | $67,000 | -30.2% | 12,090 | 0.0% | 0.02% | -21.7% |
| Q2 2015 | $96,000 | -24.4% | 12,090 | 0.0% | 0.02% | -23.3% |
| Q1 2015 | $127,000 | +0.8% | 12,090 | +15.2% | 0.03% | -11.8% |
| Q4 2014 | $126,000 | -43.0% | 10,491 | -18.7% | 0.03% | -44.3% |
| Q3 2014 | $221,000 | -2.2% | 12,904 | -31.0% | 0.06% | -4.7% |
| Q2 2014 | $226,000 | +21.5% | 18,698 | -15.0% | 0.06% | +12.3% |
| Q1 2014 | $186,000 | +44.2% | 21,985 | 0.0% | 0.06% | +39.0% |
| Q4 2013 | $129,000 | -46.2% | 21,985 | -50.2% | 0.04% | -50.6% |
| Q3 2013 | $240,000 | +1.3% | 44,159 | -24.2% | 0.08% | -6.7% |
| Q2 2013 | $237,000 | – | 58,253 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 2,000,000 | $7,820,000 | 6.23% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,530,000 | $37,262,000 | 0.78% |
| EMC Capital Management | 193,906 | $758,000 | 0.54% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 3,486,454 | $13,632,000 | 0.50% |
| ALGERT GLOBAL LLC | 344,210 | $1,346,000 | 0.43% |
| Hillsdale Investment Management Inc. | 877,000 | $3,430,000 | 0.29% |
| Stanley-Laman Group, Ltd. | 349,465 | $1,366,000 | 0.22% |
| SHEPHERD KAPLAN KROCHUK, LLC | 94,000 | $368,000 | 0.14% |
| GLOBEFLEX CAPITAL L P | 178,474 | $698,000 | 0.13% |
| Zebra Capital Management LLC | 23,622 | $92,000 | 0.10% |